Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

531
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
531
Cancer Survival Analysis01:21

Cancer Survival Analysis

827
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
827
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

704
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
704
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

486
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
486

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Blood DNA Methylation Changes During Weight-Loss Intervention and Dementia Progression Risk.

Research square·2026
Same author

Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Smartphone-Based Ecological Momentary Assessment of Pain in Older Adults Undergoing Auricular Point Acupressure for Chronic Low Back Pain: Secondary Analysis of a Randomized Controlled Trial.

JMIR formative research·2026
Same author

Rejoinder to reader reaction "Comment on 'Double robust conditional independence test for novel biomarkers given established risk factors with survival data' by Lucas Kook".

Biometrics·2026
Same author

The Time-Dependent Association Between Irritable Bowel Syndrome and All-Cause and Cause-Specific Mortality in the NIH-AARP Cohort Study.

The American journal of gastroenterology·2026

Related Experiment Video

Updated: Mar 29, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.3K

Addressing nonignorable missing data and heterogeneity in prognostic biomarker assessment.

Xinran Huang1, Ruosha Li1, Jing Ning2

  • 1Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston, USA.

Statistical Methods in Medical Research
|March 27, 2026
PubMed
Summary

This study addresses missing biomarker data in time-to-event analyses. We developed a method using instrumental variables and inverse probability weighting to estimate covariate effects on time-dependent area under the curve (AUC).

Keywords:
Alzheimer’s diseasecovariate-specific time-dependent AUCdiscriminative performancenonignorable missingprognostic biomarker

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.4K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

13.2K

Related Experiment Videos

Last Updated: Mar 29, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.3K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.4K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

13.2K

Area of Science:

  • Biostatistics
  • Biomarker Research
  • Survival Analysis

Background:

  • Time-dependent area under the curve (AUC) assesses biomarker discriminative performance for time-to-event outcomes.
  • Missing biomarker data, especially nonignorable missingness, presents significant challenges in biomarker research.
  • Covariates can influence biomarker accuracy, complicating performance evaluation.

Purpose of the Study:

  • To estimate the impact of covariates on time-dependent AUC with nonignorable missing biomarkers.
  • To propose a robust statistical method for handling complex missing data scenarios in biomarker studies.
  • To validate the proposed method using simulation and real-world data.

Main Methods:

  • Utilized instrumental variables to address identifiability issues caused by nonignorable missingness.
  • Integrated inverse probability weighting with a pseudo partial likelihood score equation for parameter estimation.
  • Established asymptotic properties of the proposed estimators for theoretical validation.

Main Results:

  • The proposed method effectively estimates covariate effects on time-dependent AUC in the presence of nonignorable missing biomarker data.
  • Simulation studies demonstrated the good finite sample performance of the developed estimators.
  • The method was successfully applied to the Alzheimer's Disease Neuroimaging Initiative (ADNI) database.

Conclusions:

  • The developed statistical approach provides a reliable way to analyze biomarker performance with complex missing data.
  • This method enhances the accurate evaluation of biomarkers in time-to-event studies, particularly when covariates are involved.
  • The findings have implications for biomarker discovery and validation in clinical research, exemplified by the ADNI study.